Slc1a5
SLC1A5 is a sodium-dependent neutral amino acid transporter that mediates the transport of neutral amino acids, such as glutamine, across the cell membrane. It plays a crucial role in cellular metabolism and various biological processes.
Lab products found in correlation
6 protocols using slc1a5
Comprehensive Protein Expression Analysis
Protein Expression Analysis by Western Blot
Quantitative Protein Analysis Workflow
Apoptosis pathway inhibitors protocol
ABT-199, epigallocatechin gallate (EGCG), CB-839, simvastatin, rapamycin and
torin-1 from Selleck Chemicals (Houston, TX, USA),
gamma-L-glutamyl-p-nitroanilide (GPNA) from Insight
Biotechnology (Wembley, Middlesex, UK), azaserine from Cambridge Bioscience
(Cambridge, UK), aminooxyacetate (AOA), sodium palmitate, dimethyl
α-ketoglutarate, oxaloacetate and citrate from Sigma-Aldrich
(Gillingham, UK), L-glutamine from Life Technologies (Paisley, UK) and
GSK2194069, SB204990, atorvastatin, pitavastatin and bafilomycin A1 from Tocris
(Abingdon, UK). Antibodies against PARP, BCL-2, MCL-1, BAX, BAK and GAPDH were
from Santa Cruz Biotechnology (Santa Cruz, CA, USA), caspase-3, caspase-9,
BCL-XL, BCL-w, BIM, PUMA, BAD, IDH2, ACL, ACO2, ATG5 and ATG7
from Cell Signaling Technology (MA, USA), BID from Prof. J. Borst (The
Netherlands Cancer Institute, Amsterdam, the Netherlands), NOXA from Millipore
(Watford, UK) and SLC1A5, GLS, GFAT, GLUD1, IDH3, FASN and HMGR from Abcam
(Cambridge, UK).
Visualizing GSC-COL1 Interactions in GBM
Correlation of circ_0000808 Expression and NSCLC
Correlation of the expression of circ_0000808 with clinicopathologic features in NSCLC patients
Parameters | N = 63 | circ_0000808 expression | p-value | |
---|---|---|---|---|
High N = 31 | Low N = 32 | |||
Age, years | ||||
≤ 60 | 25 | 12 | 13 | 0.719 |
> 60 | 38 | 20 | 18 | |
Sex | ||||
Male | 43 | 21 | 22 | 0.649 |
Female | 20 | 11 | 9 | |
Smoking history | ||||
Yes | 39 | 20 | 19 | 0.921 |
No | 24 | 12 | 12 | |
Tumor location | ||||
Left lobe | 27 | 15 | 12 | 0.513 |
Right lobe | 36 | 17 | 19 | |
Tumor size | ||||
≤ 3 | 30 | 10 | 20 | 0.008 |
> 3 | 33 | 22 | 11 | |
TNM stage | ||||
I + II stage | 49 | 21 | 28 | 0.018 |
III stage | 14 | 11 | 3 | |
Lymph node metastasis | ||||
No | 43 | 15 | 28 | < 0.001 |
Yes | 20 | 17 | 3 |
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!